"VSports在线直播" Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
- PMID: 26883384
- PMCID: PMC4756304
- DOI: 10.1038/srep21592 (V体育平台登录)
Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
"VSports最新版本" Abstract
The classical axis of renin-angiotensin system (RAS), angiotensin (Ang)-converting enzyme (ACE)/Ang II/AT1, contributes to the development of non-alcoholic fatty liver disease (NAFLD). However, the role of bypass axis of RAS (Angiotensin-converting enzyme 2 (ACE2)/Ang-(1-7)/Mas) in hepatic steatosis is still unclear. Here we showed that deletion of ACE2 aggravates liver steatosis, which is correlated with the increased expression of hepatic lipogenic genes and the decreased expression of fatty acid oxidation-related genes in the liver of ACE2 knockout (ACE2(-/y)) mice VSports手机版. Meanwhile, oxidative stress and inflammation were also aggravated in ACE2(-/y) mice. On the contrary, overexpression of ACE2 improved fatty liver in db/db mice, and the mRNA levels of fatty acid oxidation-related genes were up-regulated. In vitro, Ang-(1-7)/ACE2 ameliorated hepatic steatosis, oxidative stress and inflammation in free fatty acid (FFA)-induced HepG2 cells, and what's more, Akt inhibitors reduced ACE2-mediated lipid metabolism. Furthermore, ACE2-mediated Akt activation could be attenuated by blockade of ATP/P2 receptor/Calmodulin (CaM) pathway. These results indicated that Ang-(1-7)/ACE2/Mas axis may reduce liver lipid accumulation partly by regulating lipid-metabolizing genes through ATP/P2 receptor/CaM signaling pathway. Our findings support the potential role of ACE2/Ang-(1-7)/Mas axis in prevention and treatment of hepatic lipid metabolism. .
Figures







References
-
- Younossi Z. M. & Venkatesan C. A 2012 clinical update for internists in adult nonalcoholic fatty liver disease. Panminerva med 54, 29–37 (2012). - PubMed
-
- Day C. P. & James O. F. Steatohepatitis: a tale of two “hits”? Gastroenterology 114, 842–845 (1998). - PubMed
-
- Fromenty B., Robin M. A., Igoudjil A., Mansouri A. & Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30, 121–138 (2004). - PubMed (V体育ios版)
-
- Xu Y. Z. et al. An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Intern Med 52, 855–861 (2013). - PubMed (VSports在线直播)
VSports手机版 - Publication types
MeSH terms
- "V体育安卓版" Actions
- "V体育2025版" Actions
- VSports最新版本 - Actions
- VSports最新版本 - Actions
- V体育2025版 - Actions
- "V体育官网入口" Actions
- "V体育ios版" Actions
- V体育2025版 - Actions
- "V体育官网" Actions
- VSports app下载 - Actions
"VSports" Substances
- Actions (VSports app下载)
- Actions (VSports在线直播)
- Actions (V体育官网入口)
- VSports手机版 - Actions
- Actions (VSports手机版)
- VSports在线直播 - Actions
- Actions (V体育安卓版)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials (V体育官网入口)
Miscellaneous